Flanagan W. Michael

CIK 00018419902 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001841990

Recent Transactions

50 trades

Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−96,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-02-27−150,365→ 0 total
Award
Atrium Therapeutics, Inc.
Stock Option (Right to Buy)
2026-02-27+20,000→ 20,000 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−50,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−25,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−66,500→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−88,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−72,000→ 0 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-01-21$72.45/sh−2,558→ 85,093 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-01-21$72.45/sh−3,976→ 87,651 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-01-07$72.23/sh−2,373→ 91,627 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-12-17+27,500→ 107,695 total
Tax Payment
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-12-17$71.87/sh−13,695→ 94,000 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-09-11−20,000→ 76,500 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-09-11$38.94/sh−20,000→ 80,195 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-09-11$14.22/sh+20,000→ 100,195 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-06-11$14.22/sh+20,000→ 100,195 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-06-11$32.88/sh−20,000→ 80,195 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-06-11−20,000→ 96,500 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-03-20$31.06/sh−11,780→ 80,195 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-03-11$14.22/sh+20,000→ 111,975 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-03-11$30.13/sh−20,000→ 91,975 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-03-11−20,000→ 116,500 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-01-21$28.59/sh−1,812→ 91,975 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-01-21$28.60/sh−3,860→ 93,787 total
Award
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-01-06+50,000→ 50,000 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-01-06+25,000→ 97,647 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-12-18$32.66/sh−12,742→ 72,647 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-12-11$35.77/sh−24,000→ 85,389 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-12-11$22.47/sh+24,000→ 109,389 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-12-11−24,000→ 86,000 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-10-01$26.75/sh+62,500→ 147,889 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-10-01−62,500→ 25,000 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-10-01$47.62/sh−62,500→ 85,389 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-09-23$44.00/sh−13,153→ 72,718 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-09-23$43.89/sh−11,847→ 85,389 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-09-19+25,000→ 97,718 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-09-19+25,000→ 85,871 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-09-11$26.75/sh+62,500→ 138,265 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-09-11$40.40/sh−14,894→ 60,871 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-09-11$22.47/sh+34,000→ 109,765 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-09-11−62,500→ 87,500 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-09-11−34,000→ 110,000 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-09-11$40.40/sh−34,000→ 75,765 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-09-11$40.40/sh−62,500→ 75,765 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-06-18$39.13/sh−10,106→ 50,765 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-06-17+25,000→ 75,765 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-06-17+25,000→ 60,871 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-01-22$10.13/sh−4,129→ 35,871 total
Award
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-01-20+88,000→ 88,000 total

Companies

Recent Filings

Address

C/O ATRIUM THERAPEUTICS, INC. 10578 SCIENCE CENTER DRIVE, SUITE 125

SAN DIEGO, CA, 92121

View on SEC.gov